We have located links that may give you full text access.
English Abstract
Journal Article
Review
[Pharmacotherapy for spondyloarthropathies].
Reumatizam 2004
Since decade ago spondyloarthropathies (SpA) were neglected group of rheumatic disorders because of narrow therapeutic window. Main managing principles are described with emphasis to the assement of disease activity and distribution of pathological changes. Nonsteroidal antirheumatic drugs (NSAID) and physical therapy are still cornerstone for axial disease. Sulphasalzine and methotrexate are first choice considering peripheral arthritis. Biologic agents are effective in active vertebral and extravertebral disease. Local corticosteroid injection is favourable method for enthesitis and oligoarthritis and systemic treatment is indicated in patients during flare up of inflammation. Pamidronate and thalidomid are potential new agents for refractory cases.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app